Horchata Emerges as the Next Beverage Trend Challenging Matcha and Bubble Tea in the UK Market
EU and Mexico Sign Updated Trade Deal to Reduce Reliance on US and China
VinFast Names Founders Son as New CEO in Strategic Recalibration of Global EV Expansion
Bitcoin Price Pattern Echoes 2022 Downturn With Intensified Decline
Mutual Fund SIPs Over OneThird of 2Year Investments Show Losses Data Reveals
Chennai PortMaduravoyal Elevated Corridor Targets November 2027 Completion
Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses
PLBY Q1 2026 Earnings EPS Misses Estimates Amidst Ongoing Challenges
GAP Q1 2026 Earnings EPS Slightly Misses Estimates Amid Challenging Retail Environment
NTNX Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher
BMEA Q1 2026 Earnings Narrower Loss Beats Expectations as Clinical Progress Continues
BWBBP Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower
UFP Technologies UFPT Holds Above Support After Modest Decline Focus Shifts to Resistance
Sphere 3D Corp ANY Slips 2 as Broader Market Pressure Weighs on Bitcoin Mining Stock
Valley National Bancorp Preferred Stock VLYPO Holds Steady Near 2512 Key Support and Resistance in Focus
AppFolio Shares Slide 26 as Selling Pressure Intensifies Near Resistance
PayPay PAYP Slips 155 as Shares Test Key Support Levels
CPF LIFE vs SelfInvesting Retirement Decision Hinges on Financial Management in Old Age
CLST Q3 2025 Earnings Net Income Strengthens Amid Steady Operational Focus
LifeMD LFMD Rebounds 75 on Improved Volume Testing Resistance at 479
SpaceXs Potential SP Sector Classification A Multifaceted Challenge
RBIs 25 bps Rate Cut Raises Questions on Policy Framework Nomura Suggests
South Koreas Galaxy Robot Park Aims to Merge KPop and Robotics to Redefine Entertainment Tourism
Rigetti Computing Stock Surges on 100 Million Government Backing Report
SpaceX Starship Test Could Influence Anticipated IPO Market Watchers Say
Housing and Climate Resilience Top Latin American Agenda at World Urban Forum 13
Eli Lillys Retatrutide Shows Strong Phase 3 Data Adding WeightLoss Pipeline Momentum